Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?

One of the most important adverse effects of zoledronic acid (ZA) is osteonecrosis of the jaw (ONJ). In previous literature, several risk factors have been identified in the development of ONJ. In this study, we aimed to determine the role of trastuzumab, an antiangiogenic agent, as an independent r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilanci, Kezban Nur, Alco, Gul, Ordu, Cetin, Sarsenov, Dauren, Celebi, Filiz, Erdogan, Zeynep, Agacayak, Filiz, Ilgun, Serkan, Tecimer, Coskun, Demir, Gokhan, Eralp, Yesim, Okkan, Sait, Ozmen, Vahit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602532/
https://www.ncbi.nlm.nih.gov/pubmed/25950681
http://dx.doi.org/10.1097/MD.0000000000000671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602532/
https://www.ncbi.nlm.nih.gov/pubmed/25950681
http://dx.doi.org/10.1097/MD.0000000000000671

Ejemplares similares